Clinical trial
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
NCT02280395 is registered in ClinicalTrials.gov with Pulmatrix Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
- Lead sponsor
- Pulmatrix Inc.
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- October 31, 2014
- Completion date
- June 30, 2015
- Enrollment
- 9 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
post operative wound infection, postoperative wound infection-deep